![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
|
|||||||||
Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK. |
| Alzheimer's Disease |
|
Free Subscription
117 Alzheimers Dement |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Alzheimer's Disease is free of charge.
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105792.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107423.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106174.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107040.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106435.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105437.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107790.
PubMed
Abstract available
Genotype-phenotype interaction in Alzheimer's disease immune activation.
Alzheimers Dement. 2026;22:e70978.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107139.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105447.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106631.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105322.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106312.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106468.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106066.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106611.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106410.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106047.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105854.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107522.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106365.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107829.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107031.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107749.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e110903.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107772.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107830.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106371.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107762.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107774.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106309.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107767.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107828.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107784.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107734.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106533.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105529.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105624.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107740.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107724.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107699.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107729.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107697.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107738.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105619.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107710.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107723.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105509.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107676.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107707.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107689.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107675.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107686.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107705.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107677.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107687.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107658.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107663.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107666.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106414.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107634.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107602.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107656.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105530.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105227.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105650.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106116.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105585.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107616.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107586.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107581.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107593.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107619.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107041.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107617.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107534.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105953.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105183.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106295.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107568.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107564.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107525.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107578.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106296.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107570.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107547.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107562.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107489.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107527.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106416.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107504.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105668.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107518.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107531.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106286.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107533.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107437.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106002.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107434.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106305.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107515.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e105226.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e106382.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107470.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107452.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107471.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107465.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107467.
PubMed
Abstract available
Biomarkers.
Alzheimers Dement. 2025;21 Suppl 2:e107440.
PubMed
Abstract available
Plasma levels of an N-terminal tau fragment predict Alzheimer's and
neurodegenerative disease biomarkers in autosomal dominant Alzheimer's disease.
Alzheimers Dement. 2026;22:e71049.
PubMed
Abstract available
CSF proteomic profiling with amyloid and tau pathology identifies distinctive
sex-specific alteration of multiple proteins involved in Alzheimer's disease.
Alzheimers Dement. 2026;22:e71063.
PubMed
Abstract available
Novel insights into Alzheimer's disease through the study of individuals with
Down syndrome.
Alzheimers Dement. 2026;22:e71074.
PubMed
Identifying early changes in imaging, plasma, and digital cognitive biomarkers
that correspond to Alzheimer's disease pathology in the presence of
autopsy-confirmed co-pathologies.
Alzheimers Dement. 2026;22:e71092.
PubMed
Abstract available
Neuropsychiatric symptoms in Alzheimer's disease: Past, present, and future.
Alzheimers Dement. 2026;22:e71077.
PubMed
Abstract available
Correction to "Degradation of perineuronal nets in hippocampal CA2 explains the
loss of social cognition memory in Alzheimer's disease".
Alzheimers Dement. 2026;22:e71098.
PubMed
Defining patient-centered amyloid PET thresholds for the onset of tauopathy in
Alzheimer's disease.
Alzheimers Dement. 2026;22:e71064.
PubMed
Abstract available
Spatial patterns of tau accumulation across the Alzheimer's disease spectrum.
Alzheimers Dement. 2026;22:e71076.
PubMed
Abstract available
The Certain Uncertainty of an Alzheimer Disease Diagnosis.
Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-04205.
PubMed
Lecanemab treatment for mild alzheimer's disease with high risk of cerebral
hemorrhage: a case report.
BMC Neurol. 2026 Jan 9. doi: 10.1186/s12883-025-04581.
PubMed
Abstract available
The metabolic crossroads: glycolysis in cancer and neurodegeneration.
BMC Neurol. 2025;26:9.
PubMed
Abstract available
Anti-amyloid antibodies for Alzheimer's disease are not truly disease modifying.
BMJ. 2026;392:s28.
PubMed
Liraglutide for Alzheimer's disease . . . and other research.
BMJ. 2026;392:r2633.
PubMed
Astrocytic mGluR5-dependent calcium hyperactivity promotes amyloid-beta pathology
and cognitive impairment.
Brain. 2026;149:134-149.
PubMed
Abstract available
Neuropsychiatric symptoms in sporadic Creutzfeldt-Jakob disease.
Brain. 2025 Mar 28:awaf077. doi: 10.1093.
PubMed
Abstract available
Evaluation of neurobiochemical and behavioral responses to carvone nanoemulsion:
A neuroprotective approach for Alzheimer's disease-associated dementia in a rat
model.
Brain Res. 2026 Jan 2:150143. doi: 10.1016/j.brainres.2026.150143.
PubMed
Abstract available
Advances in plasma biomarkers for the diagnosis of Alzheimer's disease.
Brain Res. 2026;1874:150138.
PubMed
Abstract available
MicroRNA Signatures in Alzheimer's Disease and Normal-Tension Glaucoma: A
Comparative Expression Analysis of miR-128 and miR-455-3p.
Curr Alzheimer Res. 2026 Jan 6. doi: 10.2174/0115672050425207251129073017.
PubMed
Abstract available
The Cause-and-Consequence Relationships between Domestic Abuse and Alzheimer's
Disease: Identification of Five Subtypes.
Curr Alzheimer Res. 2026 Jan 5. doi: 10.2174/0115672050414496251124094000.
PubMed
Abstract available
Unlocking Neuroprotection: Potassium Channel Openers in Alzheimer's Disease.
Curr Alzheimer Res. 2026 Jan 5. doi: 10.2174/0115672050404363251128053608.
PubMed
Abstract available
Current Perspectives on Oxytocin and Alzheimer's Disease-Related Symptoms.
Curr Alzheimer Res. 2026 Jan 5. doi: 10.2174/0115672050403886251121065128.
PubMed
Abstract available
miRNAs: Promising Biomarkers for Alzheimer's Diagnosis and Treatment.
Curr Alzheimer Res. 2026 Jan 2. doi: 10.2174/0115672050427877251118111643.
PubMed
Abstract available
The Role of Microglial Cells and Cytokine Modulation in Alzheimer's Disease: A
Neuroinflammatory Perspective.
Curr Alzheimer Res. 2026 Jan 2. doi: 10.2174/0115672050412711251115023127.
PubMed
Abstract available
Hypertension is the Main Vascular Risk Factor for Cognitive Impairment,
Microvascular Pathology and Brain Atrophy in Alzheimer's Disease.
Curr Alzheimer Res. 2026 Jan 2. doi: 10.2174/0115672050399596251106033110.
PubMed
Abstract available
Unraveling the impact of risk factors on the ferroptosis-Alzheimer's disease link
for early detection.
J Alzheimers Dis. 2026 Jan 7:13872877251411331. doi: 10.1177/13872877251411331.
PubMed
Abstract available
Redefining management of mild cognitive impairment and Alzheimer's disease
through the shift from clinical to clinical-biological diagnosis: Insights from a
single-center experience.
J Alzheimers Dis. 2026 Jan 5:13872877251411461. doi: 10.1177/13872877251411461.
PubMed
Abstract available
Risk prediction of progression from normal cognitive function to Alzheimer's
disease in elderly aged 65 and above based on deep learning methods.
J Alzheimers Dis. 2026 Jan 5:13872877251410937. doi: 10.1177/13872877251410937.
PubMed
Abstract available
Microglial transcriptional profiles of a transgenic rat model closely model
Alzheimer's disease.
J Alzheimers Dis. 2026 Jan 5:13872877251410206. doi: 10.1177/13872877251410206.
PubMed
Abstract available
Investigating gender differences in Alzheimer's disease.
J Alzheimers Dis. 2026 Jan 5:13872877251410204. doi: 10.1177/13872877251410204.
PubMed
Abstract available
Association between varicella-zoster virus and Alzheimer's disease: A systematic
review and meta-analysis of comprehensive evidence from infection, treatment to
prevention.
J Alzheimers Dis. 2026 Jan 5:13872877251411573. doi: 10.1177/13872877251411573.
PubMed
Abstract available
Dementia with lewy bodies and Alzheimer s Disease overlap syndrome with PSP-like
phenotype caused by co-pathologies - a case report.
J Neurol. 2026;273:62.
PubMed
A minimally invasive dried blood spot biomarker test for the detection of
Alzheimer's disease pathology.
Nat Med. 2026 Jan 5. doi: 10.1038/s41591-025-04080.
PubMed
Abstract available
iPEX enables micrometre-resolution deep spatial proteomics via tissue expansion.
Nature. 2026;649:505-514.
PubMed
Abstract available
A timeline of structural and functional consequences to ipRGCs in a mouse model
of Alzheimer's disease.
Neurobiol Aging. 2026;160:47-63.
PubMed
Abstract available
Rare ABCA7 mutations in Alzheimer's disease and cerebral amyloid angiopathy
pathology.
Neurobiol Aging. 2026;160:33-46.
PubMed
Abstract available
A novel conditional knock-in mouse model for APOE4-to-APOE3 switching.
Neurobiol Dis. 2026;218:107244.
PubMed
Abstract available
Domain-specific changes in everyday cognition: Associations with diagnosis change
and gray matter volume change.
Neuropsychology. 2026;40:3-16.
PubMed
Abstract available
Correction: Depression as a risk factor for Alzheimer's disease: A human
post-mortem study.
PLoS One. 2026;21:e0340296.
PubMed
Abstract available
Highly sensitive chemiluminescence imaging of misfolded proteins in
neurodegenerative models.
Proc Natl Acad Sci U S A. 2026;123:e2513311123.
PubMed
Abstract available
ACSS2 upregulation enhances neuronal resilience to aging and tau-associated
neurodegeneration.
Proc Natl Acad Sci U S A. 2026;123:e2503834122.
PubMed
Abstract available
Long-term effects of forty-hertz auditory stimulation as a treatment of
Alzheimer's disease: Insights from an aged monkey model study.
Proc Natl Acad Sci U S A. 2026;123:e2529565123.
PubMed
Abstract available
Fake data from trial sites ruin studies, drug firms say.
Science. 2026;391:112-114.
PubMed
Abstract available
Thank you for your interest in scientific medicine.